SNDX
Syndax Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $1.27B | Price | $13.70 |
| Volume | 3.34M | Change | +2.32% |
| P/E Ratio | -4.0 | Open | $13.34 |
| Revenue | $23.7M | Prev Close | $13.39 |
| Net Income | $-318.8M | 52W Range | $8.58 - $22.50 |
| Div Yield | N/A | Target | $37.69 |
| Overall | 29 | Value | 40 |
| Quality | -- | Technical | 18 |
No chart data available
Stock Overview
Updated DailySyndax Pharmaceuticals Inc. (SNDX) is a leading Healthcare company in the Biotechnology industry, currently trading at $13.70 with a market capitalization of $1.27 billion. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SNDX with a volume of 3.34 million shares. The stock opened down 0.37% from yesterday's close of $13.39. Current analyst estimates project earnings of $-3.23 per share for this year, with next year targeting $-1.4.
SNDX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for SNDX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 175.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SNDX | $13.70 | +2.3% | 3.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Syndax Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW